D. Niethammer
About
In The Last Decade
D. Niethammer
281 papers receiving 8.7k citations
Peers
Comparison fields: 5 of 156
- Hematology 3.8k
- Immunology 2.3k
- Oncology 2.3k
- Molecular Biology 2.2k
- Public Health, Environmental and Occupational Health 2.0k
Countries citing papers authored by D. Niethammer
This map shows the geographic impact of D. Niethammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Niethammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Niethammer more than expected).
Fields of papers citing papers by D. Niethammer
This network shows the impact of papers produced by D. Niethammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Niethammer. The network helps show where D. Niethammer may publish in the future.
Co-authorship network of co-authors of D. Niethammer
This figure shows the co-authorship network connecting the top 25 collaborators of D. Niethammer. A scholar is included among the top collaborators of D. Niethammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Niethammer. D. Niethammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Wenn ein Kind schwer krank ist : über den Umgang mit der Wahrheit | 1 |
| 2 | 10 | |
| 3 | 323 | |
| 4 | Klinische Forschung in Deutschland: Zu den Problemen der patientenorientierten Forschung und der Durchführung von klinischen Studien in den Deutschen Universitätsklinika | 1 |
| 5 | Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. | 23 |
| 6 | Prophylactic ribavirin treatment prevents adenovirus infection in pediatric stem cell transplant recipients | 2 |
| 7 | 2 | |
| 8 | 113 | |
| 9 | Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin. | 29 |
| 10 | 41 | |
| 11 | 36 | |
| 12 | Die Transplantation hämatopoetischer Stammzellen : Teil II: Indikationen zur Transplantation von hämatopoetischen Stammzellen nach myeloablativer Therapie (Übersicht) | 3 |
| 13 | Bone marrow transplant indications for childhood leukemias: Achieving a consensus | 12 |
| 14 | 13 | |
| 15 | 4 | |
| 16 | Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. | 18 |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 11 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.